Making continuous processing a reality in the pharmaceutical industry
Posted on April 17, 2013
By: Mark Gibson, Associate Director, Drug Product Manufacture & Delivery; Marcel de Matas, Principal Scientist; Zhenyu (Henry) Huang, Senior Scientist.
AstraZeneca
Introduction The pharmaceutical industry is under intense pressure to reduce operating costs and improve productivity to address reduced cash flow, lower revenues and decreased profitability resulting from loss of market exclusivity for blockbuster drugs and low levels of success in replenishing t...
To read the full article and other articles in this issue, please register for a free account or log in.
We will not sell or give your information to a third party. See our Privacy Policy
Subscribe to our FREE newsletter and WEBINAR UPDATES
We will not sell or give your information to a third party. See our Privacy Policy
